Details for Patent: 4,931,288
✉ Email this page to a colleague
Summary for Patent: 4,931,288
Title: | Controlled release compositions (II) |
Abstract: | A controlled release composition comprising a prostaglandin and a polymeric carrier therefor comprising residues having a ratio of number average molecular weight to functionality greater than 1,000 which comprise polyethylene oxide and are cross-linked through urethane groups. |
Inventor(s): | Embrey; Mostyn (Oxford, GB2), Graham; Neil B. (Dunbartonshire, GB6) |
Assignee: | Lloyds Bank PLC (GB) |
Application Number: | 07/188,674 |
Patent Claim Types: see list of patent claims | Composition; Use; |
Drugs Protected by US Patent 4,931,288
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 4,931,288
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
United Kingdom | 7909853 | Mar 21, 1979 |
International Family Members for US Patent 4,931,288
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 14979 | ⤷ Sign Up | |||
Austria | 15444 | ⤷ Sign Up | |||
Australia | 537740 | ⤷ Sign Up | |||
Australia | 537741 | ⤷ Sign Up | |||
Australia | 5669080 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |